He also has built on this knowledge to develop far better and less toxic remedies for children. He first demonstrated in the 1980s that some neuroblastoma cells developed multiple copies of the MYCN gene, which identified a high-risk subtype of neuroblastoma, necessitating even more aggressive treatment. This discovery ushered in the current era of genomic evaluation of tumors, both in adult and pediatric oncology.This content was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health Information, an unbiased news service editorially, is an application of the Kaiser Family members Foundation, a nonpartisan healthcare policy research corporation unaffiliated with Kaiser Permanente.
Alzheimer’s treatment improves with new diagnostic method Earlier recognition and treatment for Alzheimer’s Disease are now more practical for larger segments of the populace through a far more refined use of existing, well-validated neuropsychological exams.